BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1861 related articles for article (PubMed ID: 28697342)

  • 1. Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.
    Wang Q; Hu B; Hu X; Kim H; Squatrito M; Scarpace L; deCarvalho AC; Lyu S; Li P; Li Y; Barthel F; Cho HJ; Lin YH; Satani N; Martinez-Ledesma E; Zheng S; Chang E; Sauvé CG; Olar A; Lan ZD; Finocchiaro G; Phillips JJ; Berger MS; Gabrusiewicz KR; Wang G; Eskilsson E; Hu J; Mikkelsen T; DePinho RA; Muller F; Heimberger AB; Sulman EP; Nam DH; Verhaak RGW
    Cancer Cell; 2017 Jul; 32(1):42-56.e6. PubMed ID: 28697342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The landscape of the mesenchymal signature in brain tumours.
    Behnan J; Finocchiaro G; Hanna G
    Brain; 2019 Apr; 142(4):847-866. PubMed ID: 30946477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated microenvironment-associated genomic profiles identify LRRC15 mediating recurrent glioblastoma-associated macrophages infiltration.
    Tang H; Liu W; Xu Z; Zhao J; Wang W; Yu Z; Wei M
    J Cell Mol Med; 2021 Jun; 25(12):5534-5546. PubMed ID: 33960636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment.
    Jeanmougin M; Håvik AB; Cekaite L; Brandal P; Sveen A; Meling TR; Ågesen TH; Scheie D; Heim S; Lothe RA; Lind GE
    Mol Oncol; 2020 May; 14(5):1016-1027. PubMed ID: 32171051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis.
    Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D
    Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune microenvironment of experimental rat C6 gliomas resembles human glioblastomas.
    Gieryng A; Pszczolkowska D; Bocian K; Dabrowski M; Rajan WD; Kloss M; Mieczkowski J; Kaminska B
    Sci Rep; 2017 Dec; 7(1):17556. PubMed ID: 29242629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular profiling of the tumor microenvironment in glioblastoma patients: correlation of microglia/macrophage polarization state with metalloprotease expression profiles and survival.
    Gjorgjevski M; Hannen R; Carl B; Li Y; Landmann E; Buchholz M; Bartsch JW; Nimsky C
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma.
    Guo M; Goudarzi KM; Abedi S; Pieber M; Sjöberg E; Behnan J; Zhang XM; Harris RA; Bartek J; Lindström MS; Nistér M; Hägerstrand D
    Oncogene; 2021 Aug; 40(32):5066-5080. PubMed ID: 34021259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune checkpoint molecule herpes virus entry mediator is overexpressed and associated with poor prognosis in human glioblastoma.
    Han MZ; Wang S; Zhao WB; Ni SL; Yang N; Kong Y; Huang B; Chen AJ; Li XG; Wang J; Wang DH
    EBioMedicine; 2019 May; 43():159-170. PubMed ID: 30987862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Microenvironment in Glioblastoma Subtypes.
    Chen Z; Hambardzumyan D
    Front Immunol; 2018; 9():1004. PubMed ID: 29867979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma.
    Sa JK; Chang N; Lee HW; Cho HJ; Ceccarelli M; Cerulo L; Yin J; Kim SS; Caruso FP; Lee M; Kim D; Oh YT; Lee Y; Her NG; Min B; Kim HJ; Jeong DE; Kim HM; Kim H; Chung S; Woo HG; Lee J; Kong DS; Seol HJ; Lee JI; Kim J; Park WY; Wang Q; Sulman EP; Heimberger AB; Lim M; Park JB; Iavarone A; Verhaak RGW; Nam DH
    Genome Biol; 2020 Aug; 21(1):216. PubMed ID: 32847614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology.
    Yang I; Han SJ; Sughrue ME; Tihan T; Parsa AT
    J Neurosurg; 2011 Sep; 115(3):505-11. PubMed ID: 21663411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of proneural/mesenchymal marker expression in glioblastoma: temporospatial dynamics and association with chromatin-modifying gene expression.
    Murata H; Yoshimoto K; Hatae R; Akagi Y; Mizoguchi M; Hata N; Kuga D; Nakamizo A; Amano T; Sayama T; Iihara K
    J Neurooncol; 2015 Oct; 125(1):33-41. PubMed ID: 26272600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune landscapes associated with different glioblastoma molecular subtypes.
    Martinez-Lage M; Lynch TM; Bi Y; Cocito C; Way GP; Pal S; Haller J; Yan RE; Ziober A; Nguyen A; Kandpal M; O'Rourke DM; Greenfield JP; Greene CS; Davuluri RV; Dahmane N
    Acta Neuropathol Commun; 2019 Nov; 7(1):203. PubMed ID: 31815646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor Microenvironment.
    Meisen WH; Wohleb ES; Jaime-Ramirez AC; Bolyard C; Yoo JY; Russell L; Hardcastle J; Dubin S; Muili K; Yu J; Caligiuri M; Godbout J; Kaur B
    Clin Cancer Res; 2015 Jul; 21(14):3274-85. PubMed ID: 25829396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of IKKβ expression in glioma-infiltrating microglia/macrophages is associated with defective inflammatory/immune gene responses in glioblastoma.
    Mieczkowski J; Kocyk M; Nauman P; Gabrusiewicz K; Sielska M; Przanowski P; Maleszewska M; Rajan WD; Pszczolkowska D; Tykocki T; Grajkowska W; Kotulska K; Roszkowski M; Kostkiewicz B; Kaminska B
    Oncotarget; 2015 Oct; 6(32):33077-90. PubMed ID: 26427514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome analysis reveals tumor microenvironment changes in glioblastoma.
    Hoogstrate Y; Draaisma K; Ghisai SA; van Hijfte L; Barin N; de Heer I; Coppieters W; van den Bosch TPP; Bolleboom A; Gao Z; Vincent AJPE; Karim L; Deckers M; Taphoorn MJB; Kerkhof M; Weyerbrock A; Sanson M; Hoeben A; Lukacova S; Lombardi G; Leenstra S; Hanse M; Fleischeuer REM; Watts C; Angelopoulos N; Gorlia T; Golfinopoulos V; Bours V; van den Bent MJ; Robe PA; French PJ
    Cancer Cell; 2023 Apr; 41(4):678-692.e7. PubMed ID: 36898379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
    Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
    EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Niche deconvolution of the glioblastoma proteome reveals a distinct infiltrative phenotype within the proneural transcriptomic subgroup.
    Lam KHB; Diamandis P
    Sci Data; 2022 Oct; 9(1):596. PubMed ID: 36182941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesis.
    Prabhu A; Kesarwani P; Kant S; Graham SF; Chinnaiyan P
    Neuro Oncol; 2017 Nov; 19(12):1599-1606. PubMed ID: 28541485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 94.